secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001641172-25-022271
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01, 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical faces Nasdaq delisting; CFO and director resign
----------------------------------------------------------------

- Nasdaq Board declined to review Listing Council decision; final delisting action triggered under Rule 5830 and SEC Rule 12d2-2.
- Director Michael Petersen resigned effective August 31, 2025; no disagreement cited.
- CFO Jolie Kahn resigned effective August 5, 2025; no disagreement cited.
- Company continues to work on previously announced power and cryptocurrency strategies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000164117225022271/0001641172-25-022271-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000164117225022271/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-022271

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer